Format

Send to

Choose Destination
Br J Haematol. 2019 Mar 14. doi: 10.1111/bjh.15860. [Epub ahead of print]

Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.

Author information

1
BC Cancer Centre for Lymphoid Cancer and the Department of Medical Oncology, Vancouver, Canada.
2
Department of Lymphoid Cancer Research, BC Cancer Centre for Lymphoid Cancer, Vancouver, Canada.
3
Cancer Control Research, BC Cancer Research Center and Department of Math, Statistics and Computational Science, St. Francis Xavier University, Antigonish, Canada.
4
BC Cancer Centre for Lymphoid Cancer and the Department of Pathology, Vancouver, Canada.
5
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

KEYWORDS:

DUSP22-rearranged ALK-negative ALCL; prognosis

PMID:
30873584
DOI:
10.1111/bjh.15860

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center